Mitogenic Pentapeptide

• Description :

  Mitogenic Pentapeptide (Tripalmitoyl pentapeptide) is an effective activator of B lymphocyte mitogen and polyclonal. Mitogen Pentapeptide is a synthetic N-terminal analog of E. coli outer membrane lipoproteins (cysteinyl-seryl-seryl-asparaginyl-alanine) . Mitogenic Pentapeptide can be used for the study of immune adjuvants[1][2].

• Product Name Alternative :

  Tripalmitoyl pentapeptide

• UNSPSC :

  12352209

• Target :

  MAPKAPK2 (MK2)

• Type :

  Peptides

• Related Pathways :

  MAPK/ERK Pathway

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/mitogenic-pentapeptide.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC([C@H](C)NC([C@H](CC(N)=O)NC([C@H](CO)NC([C@H](CO)NC([C@@H](NC(CCCCCCCCCCCCCCC)=O)CSCC(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O)=O)=O)=O)=O)=O

• Molecular Formula :

  C67H124N6O14S

• Molecular Weight :

  1269.80

• References & Citations :

  [1]Bessler WG, et al. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J Immunol. 1985 Sep;135 (3) :1900-5.|[2]Lex A, et al. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. J Immunol. 1986 Oct 15;137 (8) :2676-81.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [87173-03-3]